Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/10 → 12/31/13 |
Funding
- Eli Lilly and Company (H8K-MC-JZAO)
PROT# H8K-MC-JZAO: A Randomized Phase 3 Study of Tasisulam Administered as an Intravenous Infusion on Day 1 of a 28-Day Cycle vs. Paclitaxel as Second-Line Treatment in Patients with Metastatic Melanoma
- Kuzel, Timothy Michael (PD/PI)
Project: Research project